Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity

PURPOSE: The purpose of this study was to evaluate neurodevelopmental outcomes in 18-month old (corrected age) preterm infants who received an intravitreal bevacizumab (IVB) injection for the treatment of type 1 retinopathy of prematurity (ROP). METHODS: In this ten-year retrospective study, we revi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Arima, Mitsuru, Akiyama, Masato, Fujiwara, Kohta, Mori, Yujiro, Inoue, Hirosuke, Seki, Eiko, Nakama, Takahito, Tsukamoto, Shoko, Ochiai, Masayuki, Ohga, Shouichi, Sonoda, Koh-Hei
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2020
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7083318/
https://ncbi.nlm.nih.gov/pubmed/32196539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0230678
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires